The Food and Drug Administration (FDA, the Agency, or we) will hold a virtual public meeting September 20-22 titled "2022 Public Meeting of the National Antimicrobial Resistance Monitoring System." The purpose of this meeting is to discuss the progress the National Antimicrobial Resistance System (NARMS) has made towards meeting the objectives outlined in the NARMS Strategic Plan: 2021-2025.
Learn more about the meeting and register at FDA.